SCHEMBL13069009

SCHEMBL13069009

CC1(N)CCNC(=O)NC1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11198500 0.77 CRBN (0.36) CRBNSMN1; SMN2
SCHEMBL1396870 0.70
SCHEMBL11185616 0.70 CRBN (0.33) CRBNSMN1; SMN2
SCHEMBL21101214 0.70 CRBN (0.33) CRBN
SCHEMBL5492068 0.68 CRBN (0.36) CRBN
SCHEMBL21101205 0.68 CRBN (0.32) CRBN
SCHEMBL6318998 0.68
SCHEMBL14222411 0.66
SCHEMBL223245 0.66
SCHEMBL4515477 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1863477-B1 3,4-SUBSTITUTED PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF HYPERTENSION NOVARTIS AG (CH) 2010-11-03 EP disclosed